BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc.: A large extent of new developments in the neurovascular devices market stems from strides made in endovascular treatment.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Infants or neonatal are generally susceptible to a lot of diseases.

RELIEF THERAPEUTICS Holding SA announced that its wholly owned subsidiary, APR Applied Pharma Research SA, has executed a definitive agreement with Meta Healthcare Ltd., acquiring the worldwide rights, except for the United Kingdom, for a novel dosage form of a prescription drug already approved by the U.S.

Net sales amounted to SEK 94.3 million (59.3), corresponding to an increase of 59 percent in SEK and 44 percent in local currencies.

Orion and MSD announce global collaboration for the development and commercialisation ofODM-208, an investigational steroid synthesis inhibitor for the treatment of metastatic castration-resistant prostate cancer

Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirms its guidance for its financial year 2022 after delivering a solid second quarter in line with plan.

Royal Philips, a global leader in health technology, will showcase its award-winning AI-powered systems and solutions debuting at the European Congress of Radiology.

NeoImmuneTech, Inc., a T cell-focused therapeutics company, announced that the U.S. Food and Drug Administration has granted NT-I7 Orphan Drug Designation for the treatment of Glioblastoma Multiforme.

InDex Pharmaceuticals Holding AB announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office.

Agomab Therapeutics NV announced it has extended its Series B financing round with an additional close of $40.5 million, bringing the total Series B amount raised to $114 million.